TW272195B - - Google Patents

Info

Publication number
TW272195B
TW272195B TW083106101A TW83106101A TW272195B TW 272195 B TW272195 B TW 272195B TW 083106101 A TW083106101 A TW 083106101A TW 83106101 A TW83106101 A TW 83106101A TW 272195 B TW272195 B TW 272195B
Authority
TW
Taiwan
Prior art keywords
compound
preparation
pharmaceutical compositions
compositions containing
relates
Prior art date
Application number
TW083106101A
Other languages
English (en)
Chinese (zh)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW272195(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of TW272195B publication Critical patent/TW272195B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
TW083106101A 1990-09-10 1991-09-09 TW272195B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58023990A 1990-09-10 1990-09-10

Publications (1)

Publication Number Publication Date
TW272195B true TW272195B (enExample) 1996-03-11

Family

ID=24320279

Family Applications (2)

Application Number Title Priority Date Filing Date
TW080107102A TW229208B (enExample) 1990-09-10 1991-09-09
TW083106101A TW272195B (enExample) 1990-09-10 1991-09-09

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TW080107102A TW229208B (enExample) 1990-09-10 1991-09-09

Country Status (35)

Country Link
US (1) US6180781B1 (enExample)
EP (1) EP0548114B1 (enExample)
JP (1) JPH0725789B2 (enExample)
KR (1) KR960013445B1 (enExample)
CN (1) CN1030920C (enExample)
AT (1) ATE113604T1 (enExample)
AU (1) AU663471B2 (enExample)
BG (1) BG60755B2 (enExample)
CA (1) CA2091360C (enExample)
CZ (1) CZ281318B6 (enExample)
DE (2) DE19875032I2 (enExample)
DK (1) DK0548114T5 (enExample)
EE (1) EE02962B1 (enExample)
ES (1) ES2065701T3 (enExample)
FI (1) FI111078B (enExample)
HK (1) HK185996A (enExample)
HR (1) HRP920383B1 (enExample)
HU (1) HU213401B (enExample)
IE (1) IE67056B1 (enExample)
IL (1) IL99437A (enExample)
LU (1) LU90366I2 (enExample)
MX (2) MX9203396A (enExample)
MY (1) MY106644A (enExample)
NL (1) NL980012I2 (enExample)
NO (1) NO300548B1 (enExample)
NZ (1) NZ239711A (enExample)
OA (1) OA09772A (enExample)
PH (1) PH30443A (enExample)
PL (1) PL165803B1 (enExample)
PT (1) PT98905B (enExample)
SI (1) SI9111497A (enExample)
TW (2) TW229208B (enExample)
WO (1) WO1992004365A1 (enExample)
YU (1) YU48666B (enExample)
ZA (1) ZA917148B (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004365A1 (en) * 1990-09-10 1992-03-19 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
US5837699A (en) 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CN1059476C (zh) * 1996-08-21 2000-12-13 邓维鹏 金黄色铝合金硒盐电解着色方法
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
DE69804998T2 (de) * 1997-10-09 2002-12-12 Schering Corp., Kenilworth Mometasonfuroat-suspensionen zum zerstäuben
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
HUP0200871A3 (en) 1999-05-04 2004-04-28 Strakan Int Ltd Androgen glycosides and androgenic activity thereof
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
CA2537185A1 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2005051931A2 (en) * 2003-11-26 2005-06-09 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
EP1934219A1 (en) 2005-09-16 2008-06-25 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
AU2006305620A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN100389121C (zh) * 2005-12-09 2008-05-21 天津药业集团有限公司 糠酸莫美他松中间体21-羟的制备方法
CN100436473C (zh) * 2005-12-09 2008-11-26 天津药业集团有限公司 糠酸莫美他松中间体21-酯及制法
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
EP2066661A2 (en) * 2006-09-22 2009-06-10 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
KR20090069309A (ko) * 2006-09-22 2009-06-30 랜박시 래보러터리스 리미티드 포스포디에스터라제 타입-ⅳ의 저해제
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
WO2008111009A1 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
CN103497185A (zh) 2007-03-14 2014-01-08 兰贝克赛实验室有限公司 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
ES2774367T3 (es) 2009-05-29 2020-07-20 Pearl Therapeutics Inc Composiciones para el suministro respiratorio de agentes activos y métodos y sistemas asociados
US8815258B2 (en) * 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PT105058B (pt) 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法
CN107260671B (zh) * 2016-04-08 2021-03-26 天津金耀集团有限公司 一种糠酸莫米松混悬鼻喷剂组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0057401B1 (en) * 1981-02-02 1984-08-01 Schering Corporation Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4783444A (en) 1984-09-17 1988-11-08 Schering Corporation Antiglaucoma compositions and methods
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
WO1992004365A1 (en) * 1990-09-10 1992-03-19 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions

Also Published As

Publication number Publication date
AU8497491A (en) 1992-03-30
YU48666B (sh) 1999-06-15
EP0548114B1 (en) 1994-11-02
ES2065701T3 (es) 1995-02-16
CN1059911A (zh) 1992-04-01
IE67056B1 (en) 1996-02-21
FI931031L (fi) 1993-03-09
HK185996A (en) 1996-10-11
NL980012I1 (nl) 1998-05-06
ZA917148B (en) 1992-08-26
DE69104991D1 (de) 1994-12-08
NO300548B1 (no) 1997-06-16
PT98905B (pt) 1998-08-31
DK0548114T5 (da) 1995-01-30
TW229208B (enExample) 1994-09-01
AU663471B2 (en) 1995-10-12
CA2091360A1 (en) 1992-03-11
NZ239711A (en) 1992-09-25
NL980012I2 (nl) 2004-11-01
HRP920383B1 (en) 2000-04-30
EE02962B1 (et) 1997-02-17
DE19875032I2 (de) 2007-04-19
CZ38393A3 (en) 1994-01-19
SI9111497A (sl) 1998-04-30
BG60755B2 (bg) 1996-02-29
US6180781B1 (en) 2001-01-30
PH30443A (en) 1997-05-09
NO930693L (no) 1993-02-26
IE913155A1 (en) 1992-03-11
JPH0725789B2 (ja) 1995-03-22
CA2091360C (en) 1997-04-08
PL165803B1 (pl) 1995-02-28
HUT64361A (en) 1993-12-28
LU90366I2 (fr) 1999-05-05
YU149791A (sh) 1994-01-20
CN1030920C (zh) 1996-02-07
OA09772A (en) 1993-11-30
ATE113604T1 (de) 1994-11-15
PT98905A (pt) 1992-09-30
WO1992004365A1 (en) 1992-03-19
HU9300685D0 (en) 1993-06-28
FI111078B (fi) 2003-05-30
CZ281318B6 (cs) 1996-08-14
EP0548114A1 (en) 1993-06-30
JPH05506667A (ja) 1993-09-30
IL99437A (en) 1995-05-29
HRP920383A2 (en) 1998-06-30
MX9100990A (es) 1992-05-04
NO930693D0 (no) 1993-02-26
MY106644A (en) 1995-07-31
IL99437A0 (en) 1992-08-18
KR960013445B1 (ko) 1996-10-05
DE69104991T2 (de) 1995-04-20
FI931031A0 (fi) 1993-03-09
HU213401B (en) 1997-06-30
MX9203396A (es) 1992-07-31

Similar Documents

Publication Publication Date Title
TW272195B (enExample)
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
ES8307794A1 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
IL117091A (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation threreof
ZA851552B (en) Benzisoselenazolethiones,processes for their preparation and pharmaceutical products containing these compounds
IL101358A0 (en) Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it
IT8219908A0 (it) Derivati di ferro biodisponibile esenti da gastrolesivita',procedimento di preparazione e relative composizioni farmaceutiche.
CA2152771A1 (en) 7-o-ethers of taxane derivatives
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
SG153894G (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
ES8800198A1 (es) Procedimiento para preparar derivados de acidos aziridin-2- carboxilicos substituidos en n
IL66192A (en) Albomycin derivatives,their production and pharmaceutical compositions containing them
GR910300116T1 (en) 3-l-(5-thioxo-l-prolyl)thiazolidine-4-carboxylic acid and derivatives therefrom, processes for the preparation thereof and pharmaceutical compositions containing them
ZA912180B (en) Novel compounds.cephalosporins,process for their preparation and pharmaceutical compositions containing them
JO1711B1 (en) Therapeutic agents
GR79114B (enExample)
IT1255696B (it) Composto con attivita' vasodilatatrice procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
IT1269740B (it) Derivati di combretastatine ad attivita' anti-tumorale e procedimento per la loro preparazione

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent